Hypertrophic Lupus Erythematosus Successfully Treated with Triamcinolone Intralesional Injection.
- Author:
Na Young YOON
1
;
Hae Jin LEE
;
Jae Hong KIM
;
Hwa Young PARK
Author Information
1. Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea. yageyage@medimail.co.kr
- Publication Type:Case Report
- Keywords:
Hypertrophic lupus erythematosus;
Triamcinolone
- MeSH:
Acitretin;
Adrenal Cortex Hormones;
Humans;
Hydroxychloroquine;
Injections, Intralesional;
Lupus Erythematosus, Cutaneous;
Solar System;
Thalidomide;
Triamcinolone
- From:Korean Journal of Dermatology
2010;48(12):1132-1135
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hypertrophic lupus erythematosus (HLE) is a distinct and rare clinical variant of chronic cutaneous lupus erythematosus (CCLE). It is characterized by verrucous lesions and a chronic course of disease. HLE tends to be much more refractory to treatment than classical CCLE. Therefore, the traditionally available therapeutic options including sun protection, topical and oral corticosteroids, hydroxychloroquine, retinoid and thalidomide are often unable to control the disease. We report here on the successful use of triamcinolone intralesional injection in a patient with HLE and who failed to respond to conventional treatment such as acitretin and hydroxychloroquine.
